scholarly article | Q13442814 |
P2093 | author name string | Brewer C | |
Bailey C | |||
Rezae H | |||
P407 | language of work or name | English | Q1860 |
P921 | main subject | naltrexone | Q409587 |
opioid | Q427523 | ||
P304 | page(s) | 340-343 | |
P577 | publication date | 1988-09-01 | |
P1433 | published in | British Journal of Psychiatry | Q4035428 |
P1476 | title | Opioid withdrawal and naltrexone induction in 48-72 hours with minimal drop-out, using a modification of the naltrexone-clonidine technique | |
P478 | volume | 153 |
Q43989870 | 24-Hour opiate detoxification and antagonist induction at home--the 'Asturian method': a report on 1368 procedures |
Q52317035 | Antagonists in the medical management of opioid use disorders: Historical and existing treatment strategies. |
Q51117857 | Definitive treatment in the psychiatric emergency service. |
Q47569719 | Effect of adenosine analogues on the expression of opiate withdrawal in rats |
Q45170236 | Effect of alpha 2-adrenoceptor agonists on the expression of morphine-withdrawal in rats |
Q44786991 | Experience with clonidine-naltrexone for rapid opiate detoxification |
Q39456901 | Formulation and stability of naltrexone oral liquid for rapid withdrawal from methadone |
Q52266545 | Naloxone and opiate addiction. |
Q59768935 | Naltrexone and lofexidine combination treatment compared with conventional lofexidine treatment for in-patient opiate detoxification |
Q28374621 | Naltrexone shortened opioid detoxification with buprenorphine |
Q58251481 | On the Specific Effectiveness, and Under-Valuing, of Pharmacological Treatments for Addiction: A Comparison of Methadone, Naltrexone and Disulfiram with Psychosocial Interventions |
Q51470845 | Opiate detoxification under anesthesia: no apparent benefit but suppression of thyroid hormones and risk of pulmonary and renal failure. |
Q24240041 | Opioid antagonists with minimal sedation for opioid withdrawal |
Q24244653 | Opioid antagonists with minimal sedation for opioid withdrawal |
Q56289303 | Opioid antagonists with minimal sedation for opioid withdrawal |
Q35090939 | Opioid detoxification and naltrexone induction strategies: recommendations for clinical practice |
Q40694687 | Rapid heroin detoxification using a single high dose of buprenorphine |
Q52278123 | Rapid opiate detoxication in outpatient treatment: relationship with naltrexone compliance. |
Q34371727 | Rapid opiate detoxification and antagonist induction under general anaesthesia or intravenous sedation is humane, sometimes essential and should always be an option. Three illustrative case reports involving diabetes and epilepsy and a review of the |
Q41359380 | Rapid opioid detoxification using opioid antagonists: history, theory and the state of the art. |
Q41167854 | Similar efficacy of abrupt and gradual opiate detoxification |
Q52279689 | The impact of naloxone/lofexidine combination treatment on the opiate withdrawal syndrome. |
Q51488279 | Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results. |
Q48742830 | Ultra-rapid, antagonist-precipitated opiate detoxification under general anaesthesia or sedation |
Search more.